vobarilizumab
novid
mepolizumab
ocrelizumab
boomer remover
immunofluorescence
brentuximab
antimonoclonal
siltuximab
adebrelimab
robatumumab
Pfizered
Covidly
gevokizumab
lintuzumab
olaratumab
pidilizumab
matuzumab
brolucizumab
lemalesomab
drozitumab
ravulizumab
abagovomab
tislelizumab
tozinameran
double-jabbed
clotshot
COVID-positive
brazikumab
apolizumab
tixagevimab
-lim-
anti-nuclear factor
naptumomab estafenatox
onartuzumab
faralimomab
sifalimumab
ipilimumab
precoronavirus
coronavirus
alsevalimab
dacetuzumab
teneliximab
sibrotuzumab
fluorescein isocyanate
fluorescein isothiocyanate
countercorrelated
figitumumab
cilgavimab